Tuesday 24 July 2018

Reuters Health Report: GSK's two-drug HIV treatment proves itself in key tests

GSK's two-drug HIV treatment proves itself in key tests

GlaxoSmithKline's simple two-drug treatment for HIV works as well as standard triple therapy, even in people with relatively high levels of the virus that causes AIDS, clinical study results presented on Tuesday showed.

China vaccine maker hit by police, graft probes as scandal widens

Changsheng Biotechnology, the Chinese vaccine maker accused of falsifying data, plunged deeper into crisis on Tuesday as both police and the country's top graft watchdog launched investigations into the firm.

Eisai-Biogen to advance Alzheimer's drug, provide fresh hope

Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer's disease drug, BAN2401, and are working with regulators to design the next studies and gain expedited review as a breakthrough therapy.

China launches graft probe into scandal-hit vaccine firm

China's top graft buster said on Tuesday that it had begun an investigation into possible corruption at vaccine maker Changsheng Biotechnology Co, which is at the center of safety scandal that has ignited public anger.

Pepperidge Farm voluntarily recalls Goldfish Crackers on salmonella risk

Pepperidge Farm, owned by Campbell Soup, is voluntarily recalling 3.3 million units of its Goldfish Crackers due to the possible presence of salmonella, the company said on Monday.

Médecins Sans Frontières urges ViiV to speed child access to key AIDS drug

International medical charity Médecins Sans Frontières (MSF) on Monday accused specialist HIV drugmaker ViiV Healthcare of delaying access for children with the AIDS virus to a critical medicine called dolutegravir.

Medicare patients may lower drug costs by not using their insurance

(Reuters Health) - Generic medicines for many common health problems like high blood pressure and diabetes may cost Medicare patients less when they pay cash instead of using their health insurance, a U.S. study suggests.

Americans' view of marijuana is rosy, and unscientific

(Reuters Health) - Americans seem to have developed a very rosy view of marijuana that isn't backed up by science, a new study suggests.

New dads need depression screening, too

(Reuters Health) - Fathers of young children may be almost as likely as new mothers to experience symptoms of depression, a U.S. study suggests.

Gluten-free kids' foods loaded with sugar

(Reuters Health) - Children's foods that are promoted as gluten-free tend to be lacking in nutritional value and loaded with sugar just like other packaged kids' products on grocery store shelves, a U.S. study suggests.

U.N. food agency sees Brazil as major hub for arable land growth

Brazil, already a farm powerhouse, will account for an estimated 70 percent of the world's arable land growth through 2050, Alan Bojanic, a representative for the United Nations Food and Agriculture Organization (FAO), said during a conference on Monday.

Related Videos

Iraq's wetland wildlife under attack by water shortages, salinity

Chocolate-flavoured crickets can help iron deficiency, says inventor

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here